ATMI- LifeSciences Business

United States,

ATMI- LifeSciences Business is a technology provider in the field of single use bioprocess systems and consumables for the pharmaceutical and biopharmaceutical industries.

ATMI- LifeSciences Business was acquired by Pall on February 20, 2014.

Join Mergr to view all 208 acquisitions of life science companies in 2014, including 13 acquisitions by private equity firms, and 195 by strategics.

Out of 60 sectors in the Mergr database, life science ranked 12 in number of deals in 2014. The largest life science acquisition in 2014 was InterMune - which was acquired by Roche Holding AG for $8.3B.

Join Mergr to view this profile - and discover more life science acquisitions of companies like ATMI- LifeSciences Business.

What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 3.4K Private Equity Firms
  • 119K M&A Transactions
  • 129K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.